Resveratrol Trial for Relief of Pain in Pseudoachondroplasia
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if self-administered oral resveratrol can dampen
joint pain for individuals with pseudoachondroplasia compared to placebo.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston